Pharmacokinetics, Safety and Tolerability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, after Repeated Oral Administration

被引：0

作者：

Heino Stass

Dagmar Kubitza

Uwe Schühly

机构：

[1] Bayer AG,Pharma Research Centre, Institute of Clinical Pharmacology

[2] Bayer AG,Institute of Clinical Pharmacology

来源：

Clinical Pharmacokinetics | 2001年 / 40卷

关键词：

Moxifloxacin; Healthy Male Volunteer; Pefloxacin; Present Experimental Condition; Grepafloxacin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1 / 9

页数：8

共 50 条

[1] Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration
Stass, H
Kubitza, D
Schühly, U
CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 1 - 9
[2] Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans
Stass, H
Kubitza, D
CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 57 - 62
[3] Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers
Stass, H
Schühly, U
Möller, JG
Delesen, H
CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 49 - 55
[4] Effects of Sucralfate on the Oral Bioavailability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, in Healthy Volunteers
Heino Stass
Uwe Schühly
Jan-Georg Möller
Heinz Delesen
Clinical Pharmacokinetics, 2001, 40 : 49 - 55
[5] Effects of Iron Supplements on the Oral Bioavailability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, in Humans
Heino Stass
Dagmar Kubitza
Clinical Pharmacokinetics, 2001, 40 : 57 - 62
[6] Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers
Stass, H
Kubitza, D
CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 33 - 38
[7] Effects of Dairy Products on the Oral Bioavailability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, in Healthy Volunteers
Heino Stass
Dagmar Kubitza
Clinical Pharmacokinetics, 2001, 40 : 33 - 38
[8] Lack of Pharmacokinetic Interaction between Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, and Theophylline
Heino Stass
Dagmar Kubitza
Clinical Pharmacokinetics, 2001, 40 : 63 - 70
[9] Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline
Stass, H
Kubitza, D
CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 63 - 70
[10] Enhancement of human respiratory ciliary function by moxifloxacin, a new 8-methoxyfluoroquinolone
Spiteri, MA
Rotondetto, S
Thomson, CJ
Tillotson, GS
NOVEL PERSPECTIVES IN ANTIBACTERIAL ACTION, 2002, (76): : 35 - 42

← 1 2 3 4 5 →